10 research outputs found
Immunity and vaccine development efforts against Trypanosoma cruzi
Get PDFArtículo de revisión especializadoTrypanosoma cruzi (T. cruzi) is the causative agent for Chagas disease (CD). There is a critical lack of methods for prevention of infection or treatment of acute infection and chronic disease. Studies in experimental models have suggested that the protective immunity against T. cruzi infection requires the elicitation of Th1 cytokines, lytic antibodies and the concerted activities of macrophages, T helper cells, and cytotoxic T lymphocytes (CTLs). In this review, we summarize the research efforts in vaccine development to date and the challenges faced in achieving an efficient prophylactic or therapeutic vaccine against human CD.UTM
Electrochemical and surface analytical studies of carbon steel protected from corrosion in a low-chloride environment containing a phosphonate-based inhibitor
No full textSYNERGISTIC EFFECT OF N,N-BIS(PHOSPHONOMETHYL) GLYCINE AND ZINC IONS IN CORROSION CONTROL OF CARBON STEEL IN COOLING WATER SYSTEMS
No full textProduction of triacylglycerols in Escherichia coli by deletion of the diacylglycerol kinase gene and heterologous overexpression of atfA from Acinetobacter baylyi ADP1
No full textfadD deletion and fadL overexpression in Escherichia coli increase hydroxy long-chain fatty acid productivity
No full textThe corrosion inhibition performance of pectin with propyl phosphonic acid and Zn2+ for corrosion control of carbon steel in aqueous solution
No full textEssential Oil of Salvia officinalis as Novel Eco-Friendly Inhibitor for Carbon Steel in HCl Solution: Weight Loss, Electrochemical and XPS Studies
No full text
